Shingo Kano
Director Ejecutivo en Aphoenix, Inc. .
Perfil
Shingo Kano is the President & Chief Executive Officer at Aphoenix, Inc. He previously worked as an Outside Director at Medical & Biological Laboratories Co. Ltd.
Kano received his undergraduate degree from Tokyo University of Agriculture in 1987, his graduate degree from the University of Tokyo in 1989, and his doctorate from the University of Tokyo in 2002.
Cargos activos de Shingo Kano
| Empresas | Cargo | Inicio |
|---|---|---|
Aphoenix, Inc.
 Aphoenix, Inc. Medical/Nursing ServicesHealth Services Aphoenix, Inc. is a holding company that operates as a chemical genomics firm. It specializes in the affinity purification technology using special nano-scale beads and other supporting technologies, such as medicinal chemistry, mass spectroscopy, informatics and molecular, biology. The firm exploits drugs, which lack known mechanisms of action as probes for discovering druggable targets, and then develop such compounds against validated targets. The company was founded in 2002 and is headquartered in Tokyo, Japan . | Director Ejecutivo | - |
Antiguos cargos conocidos de Shingo Kano.
| Empresas | Cargo | Fin |
|---|---|---|
| MEDICAL & BIOLOGICAL LABORATORIES CO., LTD. | Director/Miembro de la Junta | - |
Formación de Shingo Kano.
| University of Tokyo | Doctorate Degree |
| Tokyo University of Agriculture | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 2 |
|---|---|
Medical & Biological Laboratories Co. Ltd.
 Medical & Biological Laboratories Co. Ltd. BiotechnologyHealth Technology Medical & Biological Laboratories Co., Ltd. engages in the research, development, manufacture and sale of biological products. It operates through the Reagents and Investment segments. The Reagent segment supplies, manufactures, and sells clinical reagents and research reagents, and its related equipment and instruments. The Investment segment deals with investments on bio-related enterprises and mediates technical partnership. The company was founded on August 23, 1969 and is headquartered in Nagoya, Japan. | Health Technology |
Aphoenix, Inc.
Aphoenix, Inc. Medical/Nursing ServicesHealth Services Aphoenix, Inc. is a holding company that operates as a chemical genomics firm. It specializes in the affinity purification technology using special nano-scale beads and other supporting technologies, such as medicinal chemistry, mass spectroscopy, informatics and molecular, biology. The firm exploits drugs, which lack known mechanisms of action as probes for discovering druggable targets, and then develop such compounds against validated targets. The company was founded in 2002 and is headquartered in Tokyo, Japan . | Health Services |
- Bolsa de valores
- Insiders
- Shingo Kano
